From the Editor
From the Editor
A saga of psychiatric serendipities…
…and of evolutions, paradigm shifts, and radical breakthroughs in psychiatric therapies.
From the Editor
Let’s tear down the silos and reunify psychiatry and neurology!
Psychiatry is as much anchored in the brain as its sister specialty neurology is.
From the Editor
Haloperidol clearly is neurotoxic. Should it be banned?
Why use an old and harmful antipsychotic when safer alternatives are available?
From the Editor
Beyond dopamine: The ‘other’ effects of antipsychotics
Ask any psychiatrist how antipsychotics (APs) work and the overwhelming response will be “by blocking dopamine receptors.”
From the Editor
Staging psychiatric disorders: A clinico-biologic model
It’s time for psychiatry to adopt a staging schema based on clinical progression and neurobiology
From the Editor
Pleiotropy of psychiatric disorders will reinvent DSM
Momentous discoveries about the shared neurogenetics of psychiatric disorders eventually will render DSM-5 obsolete
From the Editor
Brain and mind assessment in psychiatry
It’s time we comprehensively assess our patients’ brains, not just describe their minds.
From the Editor
Lab tests for psychiatric disorders: Few clinicians are aware of them
There are 273 biomarkers for schizophrenia, but none are included in DSM-5
From the Editor
The delirium/dementia treatment paradox
Older patients with delirium routinely are treated with antipsychotics, but those with dementia are not
From the Editor
Why are metabolic monitoring guidelines being ignored?
There is no excuse for failing to provide metabolic monitoring for patients receiving antipsychotics
From the Editor
Psychiatry’s ‘swords of Damocles’
With unified collaboration, we can overcome the threats that hang over psychiatry